Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Nov. 16, 1998

Oxigene initiates phase I clinical trials of combretastatin

Nov. 16, 1998

Prolifix and Chugai extend research collaboration

Nov. 16, 1998

Leo's oral vitamin D analogue induces regression, inhibits tumor growth in hepatocellular carcinoma

Nov. 13, 1998

Taiho isolates new antiproliferative agent from Nocardiopsis strain

Nov. 13, 1998

Xenova to begin phase II efficacy trials of XR-5000

Nov. 13, 1998

OSI Pharmaceuticals updates anticancer programs

Nov. 13, 1998

Favorable phase III trial results presented for Evacet at ESMO; company prepares NDA

Nov. 12, 1998

Small-molecule FGFR-1 tyrosine kinase inhibitor with nanomolar potency and good selectivity

Nov. 12, 1998

Protein tyrosine kinase inhibitors for cancer, polycystic kidney disease

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....